Document and Entity Information Document Type Document Quarterly Report Document Period End Date Document Transition Report Entity File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Address Line One Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Shell Company Entity Common Stock, Shares Outstanding Entity Central Index Key Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Period Focus Amendment Flag Consolidated Balance Sheets Statement [Table] Statement [Table] Statement [Line Items] Assets [Abstract] Assets Assets, Current [Abstract] Current assets: Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Receivables, Net, Current Accounts receivable, net of allowances of $424 and $287 Inventory, Net Inventory Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Assets, Current Total current assets Property, Plant and Equipment, Net Property and equipment, net Intangible Assets, Net (Excluding Goodwill) Intangible assets, net Operating Lease, Right-of-Use Asset Right-of-use assets Other Assets, Noncurrent Other long-term assets Restricted Cash, Noncurrent Restricted cash Assets Total assets Liabilities and Equity [Abstract] Liabilities and stockholders' (deficit) equity Liabilities, Current [Abstract] Current liabilities: Accounts Payable, Current Accounts payable Accrued Liabilities, Current Total accrued expenses and other current liabilities Accrued expenses and other current liabilities Liabilities, Current Total current liabilities Long-Term Debt, Excluding Current Maturities Long-term debt Long-term debt Other Liabilities, Noncurrent Other long-term liabilities Liabilities Total liabilities Equity, Attributable to Parent [Abstract] Stockholders' (deficit) equity: Preferred Stock, Value, Issued Preferred stock; $0.001 par value: 10,000,000 shares authorized; no shares issued and outstanding Common Stock, Value, Issued Common stock; $0.001 par value: 200,000,000 shares authorized; 44,765,928 and 44,538,264 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively Additional Paid in Capital Additional paid-in capital Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive income Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated deficit Equity, Attributable to Parent Balance at Ending period Balance at Beginning of period Total stockholders' (deficit) equity Liabilities and Equity Total liabilities and stockholders' (deficit) equity Accounts Receivable, Allowance for Credit Loss, Current Accounts receivable, Allowance Preferred Stock, Par or Stated Value Per Share Preferred stock, Par value (in dollars per share) Preferred Stock, Shares Authorized Preferred stock, shares authorized (in shares) Preferred Stock, Shares Issued Preferred stock, shares issued (in shares) Preferred Stock, Shares Outstanding Preferred stock, shares outstanding (in shares) Common Stock, Par or Stated Value Per Share Common stock, Par value (in dollars per share) Common Stock, Shares Authorized Common stock, shares authorized (in shares) Common Stock, Shares, Issued Common stock, shares issued (in shares) Common Stock, Shares, Outstanding Common stock, shares outstanding (in shares) Consolidated Statements of Operations and Comprehensive Loss Revenue from Contract with Customer, Excluding Assessed Tax Revenue Total revenue Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization Cost of revenue (excluding amortization of intangible assets) Cost, Amortization Amortization of intangible assets Gross Profit Gross profit Operating Expenses [Abstract] Operating expenses: Selling and Marketing Expense Sales and marketing Total sales and marketing General and Administrative Expense General and administrative Total general and administrative Research and Development Expense Research and development Total research and development Operating Expenses Total operating expenses Operating Income (Loss) Loss from operations Nonoperating Income (Expense) [Abstract] Other (expense) income: Interest Expense, Nonoperating Interest expense Other Nonoperating Income (Expense) Other income Nonoperating Income (Expense) Total other expense, net Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Loss before income tax expense Income Tax Expense (Benefit) Income tax expense Income tax expense Net loss Net loss Earnings Per Share, Basic Net loss per common share, basic (in dollars per share) Earnings Per Share, Diluted Net loss per common share, diluted (in dollars per share) Weighted Average Number of Shares Outstanding, Basic Weighted average common shares outstanding, basic (in shares) Weighted Average Number of Shares Outstanding, Diluted Weighted average common shares outstanding, diluted (in shares) Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] Comprehensive loss: Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Foreign currency translation adjustment Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive loss Consolidated Statements of Stockholders' Equity Equity Components [Axis] Equity Component [Domain] Common Stock [Member] Common stock Additional Paid-in Capital [Member] Additional paidin capital AOCI Attributable to Parent [Member] Accumulated other comprehensive income Retained Earnings [Member] Accumulated deficit Shares, Outstanding Balance at Ending period (in shares) Balance at Beginning of period (in shares) Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Vesting of restricted stock units Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Vesting of restricted stock units (in shares) Amount of increase to additional paid-in capital (APIC) for vesting of Restricted Stock Units and Exercise of Stock Options under share-based payment arrangement. APIC, Share-Based Payment Arrangement, Vesting of Restricted Stock Units and Exercise of Stock Options Vesting of restricted stock units and exercise of stock options Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Vesting of restricted stock units and exercise of stock options (in shares) Stock Issued During Period, Value, Employee Stock Purchase Plan Issuance of common stock under the employee stock purchase plan Stock Issued During Period, Shares, Employee Stock Purchase Plans Issuance of common stock under the employee stock purchase plan (in shares) Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Shares withheld for employee taxes Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation Shares withheld for employee taxes (in shares) APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Stock-based compensation expense Consolidated Statements of Cash Flows Net Cash Provided by (Used in) Operating Activities [Abstract] Cash flows from operating activities: Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Depreciation Depreciation expense Paid-in-Kind Interest Noncash interest expense Amount of net changes in operating lease right-of-use assets and liabilities. Net Changes in Operating Lease Right-of-use Assets And Liabilities Net changes in operating lease ROU assets and liabilities Inventory Write-down Inventory excess and obsolescence charge Share-Based Payment Arrangement, Noncash Expense Stock-based compensation expense Gain (Loss) on Disposition of Assets Loss on disposal of fixed assets Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal Gain on sale of product line Gain on sale of product line Increase (Decrease) in Operating Capital [Abstract] Change in operating assets and liabilities: Increase (Decrease) in Accounts Receivable Accounts receivable, net Increase (Decrease) in Inventories Inventory Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current and long-term assets Increase (Decrease) in Accounts Payable Accounts payable Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Accrued expenses and other current and long-term liabilities Gain (Loss), Foreign Currency Transaction, before Tax Foreign currency transaction loss Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Net Cash Provided by (Used in) Investing Activities [Abstract] Cash flows from investing activities: Payments to Acquire Property, Plant, and Equipment Purchase of property and equipment Proceeds from Sale of Productive Assets Proceeds from the sale of product line Net Cash Provided by (Used in) Investing Activities Net cash provided by investing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Cash flows from financing activities: Payments of Stock Issuance Costs Payment of accrued offering costs Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Excluding Option Exercised Vesting of restricted stock units Payment, Tax Withholding, Share-Based Payment Arrangement Payment of withholding taxes related to stock-based compensation to employees Proceeds from Stock Plans Proceeds from issuance of common stock under the employee stock purchase plan Net Cash Provided by (Used in) Financing Activities Net cash used in financing activities Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Effect of exchange rate on cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Net decrease in cash and cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Cash and cash equivalents and restricted cash, end of period Cash and cash equivalents and restricted cash, beginning of period Total cash and cash equivalents and restricted cash shown in statements of cash flows Supplemental Cash Flow Information [Abstract] Supplemental disclosure of cash flow information: Interest Paid, Excluding Capitalized Interest, Operating Activities Cash paid during the period for interest Background Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Background Risks and Liquidity Concentration Risk Disclosure [Text Block] Risks and Liquidity Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies Accrued Expenses and Other Current Liabilities Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Accrued Expenses and Other Current Liabilities Long-term Debt Long-Term Debt [Text Block] Long-term Debt Stockholders' Equity Equity [Text Block] Stockholders' Equity Sale of Product Line Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Sale of Product Line Stock-Based Compensation Share-Based Payment Arrangement [Text Block] Stock-Based Compensation Disclosure of accounting policy for the preparation of interim financial statements in conformity with generally accepted accounting principles. Interim Financial Statements Policy [Policy Text Block] Interim Financial Statements Use of Estimates, Policy [Policy Text Block] Use of Estimates Segment Reporting, Policy [Policy Text Block] Segments Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Restricted Cash Revenue [Policy Text Block] Revenue Recognition Fair Value of Financial Instruments, Policy [Policy Text Block] Fair Value of Financial Instruments Earnings Per Share, Policy [Policy Text Block] Net Loss per Common Share New Accounting Pronouncements, Policy [Policy Text Block] Recently Issued Accounting Pronouncements Schedule of Segment Reporting Information, by Segment [Table Text Block] Schedule of the items included within net loss regularly provided to the CODM Tabular disclosure of cash and cash equivalents and cash and cash equivalents restricted as to withdrawal or usage. Schedule Of Cash And Cash Equivalents And Restrictions On Cash And Cash Equivalents [Table Text Block] Schedule of reconciliation of all captions of cash, cash equivalents and restricted cash Disaggregation of Revenue [Table Text Block] Schedule of Disaggregation of Revenue Fair Value Measurements, Recurring and Nonrecurring [Table Text Block] Schedule of fair value of assets and liabilities measured on recurring basis Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of dilutive securities excluded Schedule of Accrued Liabilities [Table Text Block] Schedule of Accrued Expenses and Other Current Liabilities Schedule of Debt [Table Text Block] Schedule of long-term debt Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Schedule of warrants outstanding to purchase common stock Tabular disclosure of information pertaining to warrant activity. Schedule Of Warrant Activity [Table Text Block] Summary of warrant activity Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Schedule of stock based compensation expense categories in statement of operations Share-Based Payment Arrangement, Option, Activity [Table Text Block] Schedule of stock option activity Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value [Table Text Block] Schedule of weighted average assumptions Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Schedule of service-based (RSUs) Share-Based Payment Arrangement, Performance Shares, Activity [Table Text Block] Schedule of performance-based (RSUs) Unusual Risk or Uncertainty [Table] Unusual Risk or Uncertainty [Line Items] Class of Warrant or Right, Number of Securities Called by Warrants or Rights Warrants to purchase shares of the company Schedule of Segment Reporting Information, by Segment [Table] Segments [Axis] Segments [Domain] Represents information pertaining to single reportable segment. Single Reportable Segment [Member] Single reportable segment Segment Reporting Information [Line Items] Segments Number of Reportable Segments Number of reportable segment Selling and Marketing Expense [Abstract] Sales and marketing: Amount of expense pursuant to sales and sales management. Sales And Sales Management Expense Sales and sales management Amount of expense pursuant to international selling and marketing. International Selling And Marketing Expense International Other Selling and Marketing Expense Other sales and marketing General and Administrative Expense [Abstract] General and Administrative: Amount of finance and legal expense. Finance And Legal Expense Finance and Legal Other General and Administrative Expense Other general and administrative Research and Development Expense [Abstract] Research and Development: Amount of clinical expense. Clinical Expense Clinical Amount of regulatory and quality costs. Regulatory And Quality Costs Regulatory and quality Other Research and Development Expense Other research and development Segment Reporting, Other Segment Item, Amount Other segment items Disaggregation of Revenue [Table] Customer [Axis] Customer [Domain] OviTex [Member] OviTex [Member] OviTex OviTex PRS [Member] OviTex PRS [Member] OviTex PRS Represents the information pertaining to other customers. Other [Member] Other Geographical [Axis] Geographical [Domain] Non-US [Member] Non-US Disaggregation of Revenue [Line Items] Revenue disaggregated Represents incremental costs incurred in obtaining a contract. Incremental Costs Of Obtaining A Contract Incremental costs of obtaining a contract Fair Value, Recurring and Nonrecurring [Table] Measurement Frequency [Axis] Measurement Frequency [Domain] Fair Value, Recurring [Member] Fair Value, Recurring Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value, Inputs, Level 1 [Member] Level 1 Financial Instrument [Axis] Financial Instruments [Domain] Money Market Funds [Member] money market fund Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value of Financial Instruments Cash and Cash Equivalents, Fair Value Disclosure Cash equivalents Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Restricted Stock Units (RSUs) [Member] Restricted Stock Units (RSUs) Unvested restricted stock units Represents information pertaining to common stock warrants. Common stock warrants Represents information pertaining to common stock warrants issued with credit facility. Common Stock warrants Issued With Credit Facility [Member] Common stock warrants issued with credit agreement Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Represents information pertaining to pre-funded common stock warrants. Prefunded Common Stock Warrants [Member] Pre-funded common stock warrants Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Potentially dilutive securities Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Total Class of Warrant or Right, Exercise Price of Warrants or Rights Warrants exercise price Employee-related Liabilities, Current Compensation and related benefits Accrued Professional Fees, Current Third-party and professional fees Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to contract manufacturer due. Accrued Expenses, Amount Due To Contract Manufacturer Amounts due to contract manufacturer Operating Lease, Liability, Current Current portion of operating lease liabilities Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Carrying value of current portion of obligation payable pertaining to Research and development. Research And Development Expenses Payable Current Research and development expenses Taxes Payable, Current Income/sales tax payable Other Accrued Liabilities, Current Other Schedule of Long-Term Debt Instruments [Table] Long-Term Debt, Type [Axis] Long-Term Debt, Type [Domain] Represents information pertaining to Perceptive credit facility. Perceptive Credit Facility [Member] Perceptive term loan Debt Instrument [Line Items] Long-term Debt Debt Instrument, Face Amount Term loan Debt amount Unamortized Debt Issuance Expense Unamortized issuance costs Represents information pertaining to MidCap Term loans. MidCap term loan Represents information pertaining to initial loan warrants. Initial Loan Warrants [Member] Initial loan warrants Represents information pertaining to perceptive additional warrants. Perceptive Additional Warrants [Member] Perceptive additional warrants Statistical Measurement [Axis] Statistical Measurement [Domain] Minimum [Member] Minimum Maximum [Member] Maximum Line of Credit Facility, Maximum Borrowing Capacity Maximum borrowing capacity Line of Credit Facility, Current Borrowing Capacity Initial loan capacity Line of Credit Facility, Remaining Borrowing Capacity Additional loan capacity Debt Instrument, Maturity Date Maturity date Debt Instrument, Interest Rate, Stated Percentage Interest Rate (as a percent) Debt Instrument, Basis Spread on Variable Rate Variable Interest Rate (as a percent) Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration] Minimum percentage of base rate pursuant to debt instrument Debt Instrument, Floor Base Rate Interest rate, floor (as a percent) Debt Instrument, Interest Rate, Increase (Decrease) Applicable margin increase Percentage of prepayment premium payable on outstanding principal amount prepaid. Debt Instrument, Prepayment Premium Percentage Prepayment premium Debt Issuance Costs, Gross Additional debt issuance cost The number of warrants exercised. Class of Warrant or Right, Exercised Number of warrants exercised Exercised Amount of threshold minimum liquidity the company should maintain as per terms of debt agreement. Debt Instrument, Covenant, Threshold Minimum Liquidity Minimum liquidity Interest Expense, Debt Interest expenses Amortization of Debt Issuance Costs Amortization of debt issuance costs Temporary Equity, by Class of Stock [Table] Sale of Stock [Axis] Sale of Stock [Domain] Equity Distribution Agreement [Member] Equity Distribution Agreement Temporary Equity [Line Items] Stockholders' Equity The maximum amount of shares that can be sold under the at-the-market programs. Common Stock Available Under ATM Value Of Shares Sold Under Equity Distribution Agreement Value Of Shares Sold Under Equity Distribution Agreement Value of shares sold Represents information pertaining to common stock warrants expiring in 2028. Common stock warrants expiring in 2028 Represents information pertaining to common stock warrants expiring in 2027. Common stock warrants expiring in 2027 Class of Warrant or Right, Outstanding Ending balance Beginning balance Warrants outstanding Class of Warrant or Right, Date from which Warrants or Rights Expire Class of Warrant or Right, Date from which Warrants or Rights Expire Expiration dates A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. Class of Warrant or Right, Outstanding [Roll Forward] Summary of warrant activity Disposal Groups, Including Discontinued Operations [Table] Disposal Group Name [Axis] Disposal Group Name [Domain] Asset Purchase Agreement ("APA") with MiMedx Group, Inc. ("MDXG") to sell certain assets (the "Transaction") related to NIVIS Fibrillar Collagen Pack Device ("NIVIS"). Disposal Group, Transaction [Member] Transaction Disposal Group Classification [Axis] Disposal Group Classification [Domain] Disposal Group, Not Discontinued Operations [Member] Disposal Group, Held-for-Sale or Disposed of by Sale, Not Discontinued Operations [Member] Disposal Group, Held-for-Sale or Disposed of by Sale, Not Discontinued Operations Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member] Disposal Group, Disposed of by Sale, Not Discontinued Operations Counterparty Name [Axis] Counterparty Name [Domain] Represents the information pertaining to MiMedx Group, Inc. MiMedx Group, Inc [Member] MiMedx Group, Inc. Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Sale of Product Line Disposal Group, Including Discontinued Operation, Inventory Net carrying value Disposal Group, Including Discontinued Operation, Intangible Assets Carrying value The future revenue-sharing payments based on the net sales of NIVIS during the first two years following its launch by MDXG. Disposal Group, Future Revenue Sharing Payments Revenue sharing payments The cash inflow from additional consideration received on sale of asset. Proceeds From Additional Consideration On Sale Of Asset Consideration received for inventory on-hand Any consideration in excess consideration is considered variable consideration that is fully constrained. Disposal Group, Future Revenue Sharing Payments, Variable Consideration Variable consideration Disposal Group, Including Discontinued Operation, Consideration Consideration determined The cash inflow from revenue share payments collected. Proceeds From Revenue Share Payments Revenue share payments collected Amount of minimum revenue share payments receivable. Minimum Revenue Share Payments Receivable Amount minimum revenue share payments receivable Amount of minimum revenue share payments receivable classified as current. Minimum Revenue Share Payments Receivable Current Amount minimum revenue share payments receivable current The amount of increase (decrease) in the variable consideration during the period. Disposal Group Future Revenue Sharing Payments, Increase (Decrease) in Variable Consideration Variable Consideration Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Plan Name [Axis] Plan Name [Domain] This member stands for 2019 Equity Incentive Plan. 2019 Equity Incentive Plan Represents information relating to service based restricted stock units. Performance Based Restricted Stock Units [Member] Performance based restricted stock units Represents information relating to service based restricted stock unit Service Based Restricted Stock Unit [Member] Service based restricted stock unit Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Stock-Based Compensation Represents about number of equity incentive plans. Equity Incentive Plans, Number Number of equity incentive plans Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Number of authorized shares Common Stock, Capital Shares Reserved for Future Issuance Shares available for future issuance Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Contractual term Number of inducement stock option outstanding. Share-based Compensation Arrangement by Share-based Payment Award, Stock Options, Inducement Grants in Period Inducement grants of Stock Options Number of inducement restricted stock units outstanding. Share-based Compensation Arrangement by Share-based Payment Award, Options, Inducement Grants in Period Inducement grants Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Aggregate intrinsic value of exercisable options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Aggregate intrinsic value of outstanding options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted average grant date fair value, Options (per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Aggregate intrinsic value of exercised options Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted average grant date fair value, Equity Instruments (per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding Aggregate intrinsic value Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Unrecognized compensation expense Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Weighted average period for recognition of unrecognized expenses Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Vest Range Statement of Income Location, Balance [Axis] Statement of Income Location, Balance [Domain] Selling and Marketing Expense [Member] Sales and marketing General and Administrative Expense [Member] General and administrative Research and Development Expense [Member] Research and development Share-Based Payment Arrangement, Expense Total stock-based compensation Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Number of shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Balance at end of period Balance at beginning of period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Canceled/forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Vested and expected to vest at end of period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Exercisable at end of period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Weighted average exercise price per share Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Balance at end of period (in dollars per share) Balance at beginning of period (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Granted ( in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Canceled/forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Vested and expected to vest at end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Exercisable at end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Weighted average remaining contractual term (years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Weighted average remaining contractual term, outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Weighted average remaining contractual term, Vested and expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Weighted average remaining contractual term, Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Expected term (in years) Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met. Service Based Restricted Stock Units [Member] Service Based Restricted Stock Units Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Outstanding at end of period Outstanding at beginning of period Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Canceled/forfeited N/A Rule 10b51 Arr Modified [Flag] Rule 10b5-1 Arrangement Modified N/A Non Rule 10b51 Arr Modified [Flag] Non-Rule 10b5-1 Arrangement Modified